NeoGenomics, Inc. (NGNM) Reports Q2 EPS Loss of $0.01

July 20, 2011 7:24 AM EDT
NeoGenomics, Inc. (: NGNM) reported Q2 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $9.52 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings